Aurora Cannabis (ACB)
(Delayed Data from NSDQ)
$7.38 USD
-0.23 (-3.02%)
Updated May 17, 2024 04:00 PM ET
After-Market: $7.30 -0.08 (-1.08%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ACB 7.38 -0.23(-3.02%)
Will ACB be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ACB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACB
Strength Seen in Canopy Growth (CGC): Can Its 11.0% Jump Turn into More Strength?
Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates
ACB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aurora Cannabis (ACB) Moves 46.0% Higher: Will This Strength Last?
Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?
Aurora Cannabis Inc. (ACB) Suffers a Larger Drop Than the General Market: Key Insights
Other News for ACB
Canadian Cannabis LPs Portfolio Up 14% This Week; Still Down 21% MTD
3 Short-Squeeze Stocks to Buy Before June for 50% Returns
Dear CGC Stock Fans, Mark Your Calendars for May 30
Biden administration reportedly moves to reclassify marijuana (update)
DOJ set to post plans for marijuana reclassification, Politico says